(EMAILWIRE.COM, December 20, 2018 ) The global bioreactor market comprising volume market analysis of stainless steel, single-use, and glass bioreactors is expected to reach to USD 1,417 Million by 2021 from USD 955 Million in 2015, at a CAGR of 6.8% between 2015 and 2021.

Factors such as the increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies and growing biologics to drive the growth of the global bioreactors market. This report mainly considers three types of bioreactor material Glass, stainless steel, and single-use bioreactors. Glass bioreactors are majorly used for R&D and scaling up process development. They are also used in academic and research institutes. The single-use segment commanded around 41% of the global bioreactors market, in terms of volume, in 2015.

Ask For Discount:
https://www.marketsandmarkets.com/discountreports.asp?id=59253123

End user Market Analysis:

On the basis of end-user, the bioreactor market has been segmented into R&D departments and biopharmaceutical manufacturers. The R&D departments segment is expected to register the highest growth rate from 2016 to 2021 owing to increased bioreactor usage in process development. Contract manufacturing organizations (CMOs) on the other hand are expected to gain traction in the coming years due to rise in outsourcing needs for biologics manufacturers as a result of increased demand of biologics.

Geographic Analysis:

In this report, the bioreactors market is segmented into four major geographic segments, namely, North America, Europe, Asia-Pacific, and Rest of the World. In terms of volume, North America accounted for 42% of the total bioreactors market, by region. Asia-Pacific countries are expected to show the highest growth, being emerging markets for bioreactors owing to the expansion of the biopharmaceutical sector in this region. China, for instance, is the most preferred destination for leading biopharma companies for the production of biologics, and has attracted significant investment in this field.

Request Bundle of Reports:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=59253123

Some of the leading players offering bioreactor products are

Sartorius AG (Germany),
Thermo Fisher Scientific, Inc. (U.S.),
Merck KGaA (Germany),
GE Healthcare (A subsidiary of General Electric Company) (U.S.),
Danaher Corporation (U.S),
and Eppendorf AG (Germany).